The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.
This study aimed to understand the characteristics of dysphagia through fluoroscopy in older adults with mild cognitive impairment ... Mexico City between June 2022 and April 2023. The sample size was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback